Search Results 91-100 of 15048 for infliximab

  1. Biomarkers of Treatment Response in Rheumatoid Arthritis - Mayo Clinic

    Participation eligibility · TNF inhibitors (adalimumab, certolizumab, etanercept, golimumab, or infliximab) · Abatacept (Orencia; IV or SC) · Tocilizumab (Actemra; ...

  2. A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

    ... infliximab; Intolerance to at least 2 anti-TNF-alpha biologic ... Has received infliximab, infliximab biosimilar, or golimumab intravenous (IV) ...

  3. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    At least one 6-week induction regimen of infliximab (≥5 mg/kg IV at Weeks 0 ... Approved biologics: infliximab, adalimumab, certolizumab, vedolizumab ...

  4. Could Pain in the Finger Joints Be a Sign of Rheumatoid Arthritis? - Mayo Clinic News Network

    Medications in this category include infliximab (Remicade) and etanercept (Enbrel). Work closely with a rheumatologist to determine the treatment approach ...

  5. Drugs and Supplements that Start with R - Mayo Clinic

    Infliximab (intravenous route). Renflexis. Also known as. Infliximab-abda (intravenous route). Reno-30. Also known as. Diatrizoate (intravenous route). Reno-60.

  6. Juvenile idiopathic arthritis - Diagnosis and treatment - Mayo Clinic

    ... infliximab (Remicade, Inflectra, others). These medications can help reduce systemic inflammation and prevent joint damage. They may be used with DMARDs and ...

  7. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Prior use of any TNFα antagonist including (but not limited to) infliximab, adalimumab, golimumab, certolizumab, or biosimilar agents at any time. Prior or ...

  8. Publications - Sunanda V. Kane, M.D. - Mayo Clinic

    Use of Biosimilars to Infliximab During Pregnancy in Women With Inflammatory Bowel Disease: Results From the Pregnancy in Inflammatory Bowel Disease and ...

  9. A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) - Mayo Clinic

    ... infliximab, adalimumab, or certolizumab pegol) per study criteria; Have screening laboratory test results within protocol-specified parameters. Exclusion ...

  10. Treatment of IgG4-Related Disease With Revlimid and Rituximab - Mayo Clinic

    Treatment with infliximab, adalimumab, or etanercept within the past 12 months. Currently taking azathioprine, 6-mercaptopurine, methotrexate, mycophenolate ...